Literature DB >> 28677143

The physiological role of the amyloid precursor protein as an adhesion molecule in the developing nervous system.

Lucas J Sosa1, Alfredo Cáceres2,3, Sebastián Dupraz4, Mariana Oksdath1, Santiago Quiroga1, Alfredo Lorenzo5.   

Abstract

The amyloid precursor protein (APP) is a type I transmembrane glycoprotein better known for its participation in the physiopathology of Alzheimer disease as the source of the beta amyloid fragment. However, the physiological functions of the full length protein and its proteolytic fragments have remained elusive. APP was first described as a cell-surface receptor; nevertheless, increasing evidence highlighted APP as a cell adhesion molecule. In this review, we will focus on the current knowledge of the physiological role of APP as a cell adhesion molecule and its involvement in key events of neuronal development, such as migration, neurite outgrowth, growth cone pathfinding, and synaptogenesis. Finally, since APP is over-expressed in Down syndrome individuals because of the extra copy of chromosome 21, in the last section of the review, we discuss the potential contribution of APP to the neuronal and synaptic defects described in this genetic condition. Read the Editorial Highlight for this article on page 9. Cover Image for this issue: doi. 10.1111/jnc.13817.
© 2017 International Society for Neurochemistry.

Entities:  

Keywords:  APP; adhesion molecule; connectopathy; neurodegeneration; neurodevelopment; plasticity

Mesh:

Substances:

Year:  2017        PMID: 28677143     DOI: 10.1111/jnc.14122

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  26 in total

1.  APP-Mediated Signaling Prevents Memory Decline in Alzheimer's Disease Mouse Model.

Authors:  Carole Deyts; Mary Clutter; Nicholas Pierce; Paramita Chakrabarty; Thomas B Ladd; Anna Goddi; Awilda M Rosario; Pedro Cruz; Kulandaivelu Vetrivel; Steven L Wagner; Gopal Thinakaran; Todd E Golde; Angèle T Parent
Journal:  Cell Rep       Date:  2019-04-30       Impact factor: 9.423

2.  A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition.

Authors:  Darrell Sawmiller; Ahsan Habib; Huayan Hou; Takashi Mori; Anran Fan; Jun Tian; Jin Zeng; Brian Giunta; Paul R Sanberg; Mark P Mattson; Jun Tan
Journal:  Biol Psychiatry       Date:  2019-05-02       Impact factor: 13.382

3.  Expression of AHI1 Rescues Amyloidogenic Pathology in Alzheimer's Disease Model Cells.

Authors:  Lai-Lei Ting; Hsien-Tsung Lu; Shu-Fen Yen; Thi Huong Ngo; Fang-Yu Tu; I-Shih Tsai; Yi-Hua Tsai; Fu-Yen Chang; Xiao-Jiang Li; Shihua Li; Ching-Kuo Lee; Shu-Huei Kao; Yu-Min Kuo; Yung-Feng Lin
Journal:  Mol Neurobiol       Date:  2019-05-07       Impact factor: 5.590

4.  Insertion of the Icelandic Mutation (A673T) by Prime Editing: A Potential Preventive Treatment for Familial and Sporadic Alzheimer's Disease.

Authors:  Guillaume Tremblay; Joël Rousseau; Cedric Happi Mbakam; Jacques P Tremblay
Journal:  CRISPR J       Date:  2022-02-07

5.  The interplay of aryl hydrocarbon receptor/WNT/CTNNB1/Notch signaling pathways regulate amyloid beta precursor mRNA/protein expression and effected the learning and memory of mice.

Authors:  Majid Keshavarzi; Fatemeh Moradbeygi; Keivan Mobini; Ali Ghaffarian Bahraman; Parisa Mohammadi; Afsaneh Ghaedi; Afshin Mohammadi-Bardbori
Journal:  Toxicol Res (Camb)       Date:  2021-12-29       Impact factor: 3.524

6.  DYRK1A regulates the bidirectional axonal transport of APP in human-derived neurons.

Authors:  Iván Fernandez Bessone; Jordi Navarro; Emanuel Martinez; Karina Karmirian; Mariana Holubiec; Matias Alloatti; Livia Goto-Silva; Cayetana Arnaiz Yepez; Daniel Martins-de-Souza; Juliana Minardi Nascimento; Luciana Bruno; Trinidad M Saez; Stevens K Rehen; Tomás L Falzone
Journal:  J Neurosci       Date:  2022-07-08       Impact factor: 6.709

7.  APP Binds to the EGFR Ligands HB-EGF and EGF, Acting Synergistically with EGF to Promote ERK Signaling and Neuritogenesis.

Authors:  Odete A B da Cruz E Silva; Sandra I Vieira; Joana F da Rocha; Luísa Bastos; Sara C Domingues; Ana R Bento; Uwe Konietzko
Journal:  Mol Neurobiol       Date:  2020-10-02       Impact factor: 5.590

Review 8.  Alzheimer's Disease and Diabetes: Insulin Signaling as the Bridge Linking Two Pathologies.

Authors:  Jonathan Chang-Cheng Shieh; Pai-Tsang Huang; Yung-Feng Lin
Journal:  Mol Neurobiol       Date:  2020-01-03       Impact factor: 5.590

Review 9.  Interactions of Amyloid-β with Membrane Proteins.

Authors:  Benita Wiatrak; Janusz Piasny; Amadeusz Kuźniarski; Kazimierz Gąsiorowski
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

10.  Amyloid β and Amyloid Precursor Protein Synergistically Suppress Large-Conductance Calcium-Activated Potassium Channel in Cortical Neurons.

Authors:  Kenji Yamamoto; Ryo Yamamoto; Nobuo Kato
Journal:  Front Aging Neurosci       Date:  2021-06-03       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.